» Articles » PMID: 21778133

Gene Therapy of Liver Diseases: a 2011 Perspective

Overview
Specialty Gastroenterology
Date 2011 Jul 23
PMID 21778133
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Liver diseases including inherited metabolic disorders, chronic viral hepatitis, liver cirrhosis and primary and metastatic liver cancer constitute a formidable health problem because of their high prevalence and the important limitations of current therapies. Gene therapy, a procedure based on the transfer of therapeutic genes to tissues, has been used since the 1990s as a new approach to treating a number of incurable conditions. After a period of lights and shades recent success in treating several devastating diseases like inherited immune deficiency disorders, beta-thalassemia, or inherited blindness appear to herald a new era where gene therapy can be listed among standard therapy options for a wide variety of human conditions. In this review, we provide information illustrating the potentiality of gene therapy in the management of liver diseases lacking other effective therapies.

Citing Articles

Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver.

Gonzalez-Moreno L, Santamaria-Cano A, Paradela A, Martinez-Chantar M, Martin M, Perez-Carreras M Mol Genet Metab Rep. 2023; 35:100967.

PMID: 36967723 PMC: 10031141. DOI: 10.1016/j.ymgmr.2023.100967.


Liver-specific Gene Delivery Using Engineered Virus-Like Particles of Hepatitis E Virus.

Lee E, Kim J, Hur W, Choi J, Kim S, Park D Sci Rep. 2019; 9(1):1616.

PMID: 30733562 PMC: 6367430. DOI: 10.1038/s41598-019-38533-7.


Immunological landscape and immunotherapy of hepatocellular carcinoma.

Prieto J, Melero I, Sangro B Nat Rev Gastroenterol Hepatol. 2015; 12(12):681-700.

PMID: 26484443 DOI: 10.1038/nrgastro.2015.173.


Regulation of hepatocyte identity and quiescence.

Berasain C, Avila M Cell Mol Life Sci. 2015; 72(20):3831-51.

PMID: 26089250 PMC: 11114060. DOI: 10.1007/s00018-015-1970-7.


Lipid nanoparticles for gene delivery.

Zhao Y, Huang L Adv Genet. 2014; 88:13-36.

PMID: 25409602 PMC: 5006671. DOI: 10.1016/B978-0-12-800148-6.00002-X.